AccessMyLibrary provides FREE access to over 30 million articles from top publications available through your library.
Create a link to this page
Copy and paste this link tag into your Web page or blog:
2003 FEB 13 - (NewsRx.com & NewsRx.net) -- A new study finds that many women do not receive adjuvant chemotherapy after surgery for breast cancer as recommended by the U.S. National Institutes of Health (NIH). Further, the older the woman, the less likely she is to receive adjuvant chemotherapy.
Xianglin L. Du, MD, PhD, lead investigator of the study and assistant professor of internal medicine and geriatrics at the University of Texas Medical Branch at Galveston, explained that a NIH consensus conference in 1990 determined that physicians should recommend chemotherapy after surgery for pre- and postmenopausal women with early-stage breast cancer that has spread to the lymph nodes or who have a tumor larger than 1 cm with negative hormone receptor status.
The study, published in Annals of Internal Medicine, described he patterns of adjuvant chemotherapy in 5101 women aged 20 or older with operable breast cancer, identified by the New Mexico Tumor Registry between 1991 and 1997. Overall, 29% of women received chemotherapy. Sixty-six percent of women aged 45 and younger received chemotherapy, vs. 44% ...